Research and Development

Showing 15 posts of 9607 posts found.

Arrow purchase adds another string to AZ’s biotech bow

February 9, 2007 Research and Development

AstraZeneca has bought London-based Arrow Therapeutics for $150 million (£76 million) in cash, adding to a long list of recent …

MorphoSys opens UK headquarters in Oxford

January 31, 2007 Research and Development

A leading producer of antibodies for biotech drug research and manufacturing has opened a new UK headquarters in Oxford.MorphoSys generates …

Vectura buys Innovata

January 22, 2007 Research and Development biotech, vectura

 Pulmonary product development in the UK has received a boost following the takeover of drug developer Innovata by biotech company …

Wellcome Trust issues first grants to encourage drug discovery

January 19, 2007 Research and Development

The first awards have been made in the Wellcome Trust's £91 million, five-year plan for novel drugs to tackle obesity, …

World’s first stem cell trial for stroke likely to get green light

January 19, 2007 Research and Development ReNeuron, stem cell, stroke

A cutting-edge stem cell clinical trial for chronic stroke patients looks set to go ahead later this year.Biotech company ReNeuron, …

Are you in control of your new products?

January 19, 2007 Research and Development academia, innovation

The quest to convert inventions (i.e. promising ideas) into innovations (i.e. commercial products) is a central and vital feature of …

Europe’s biotech sector to flourish in 2007

January 8, 2007 Research and Development Europe

Analysts are predicting that 2007 will be a strong year for European biotech, which is forecast to outstrip the growth …

New class of anti-angiogenesis agents gets 2 million euro boost

January 8, 2007 Research and Development

Two European biotech companies have received a grant of two million euros to jointly develop a new class of anti-angiogenesis …

Roche targets new central nervous system drugs

January 5, 2007 Research and Development

Swiss-based Roche has forged a partnership that could lead to the development of new treatments for schizophrenia, cognitive disorders, Parkinson's …

GSK buys Praecis Pharmaceuticals for $59 million

January 4, 2007 Research and Development, Sales and Marketing

GlaxoSmithKline has bought US-based biotech company, Praecis, to further boost its novel cancer pipeline.Its acquisition of Praecis Pharmaceuticals follows the …

Diabetic kidney disease drug hits safety obstacle

January 4, 2007 Research and Development, Sales and Marketing

Swiss-based biotech company Speedel has axed its current phase III trial of SPP301 in diabetic kidney disease because of patient …

Pharma failing to address MRSA drugs market

January 2, 2007 Research and Development, Sales and Marketing

News that a new strain of the MRSA bug has reached Europe from the US has left drug developers under …

Novartis enters late-stage trials for new hepatitis C drug

December 21, 2006 Research and Development, Sales and Marketing

Novartis, in collaboration with a US biotech company, has initiated phase III trials of a chronic hepatitis C drug that …

Protherics raises

December 19, 2006 Research and Development

UK-based biotech company Protherics has raised £38 million, which will be split in a three-pronged move to expand its development …

GSK’s mock vaccine gets EU positive opinion

December 19, 2006 Research and Development

GlaxoSmithKline Biological's mock pandemic flu vaccine has received a positive opinion from EU regulators.Daronix is intended to protect against flu …
The Gateway to Local Adoption Series

Latest content